MedDataX Logo

Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

NCT ID: NCT03552003

Last Updated: 2022-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-10

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to develop a prognostic index for elderly patients with newly diagnosed cHL starting from a prospective observational study of consecutive cases registered after the completion of the Comprehensive Geriatric Assessment (CGA)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

NCT06822855

Classical Hodgkin Lymphoma Classical Hodgkin Lymphoma Recurrent Classical Hodgkin Lymphoma Refractory
RECRUITING

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT05524298

Low Grade Non-Hodgkin's Lymphoma, Adult
RECRUITING

A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)

NCT06835530

Diffuse Large B Cell Non-Hodgkin Lymphoma
RECRUITING PHASE2

Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

NCT03535948

Hodgkin Lymphoma, Adult
UNKNOWN

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

NCT01829958

Non Hodgkin Lymphoma (NHL) Diffuse Large B-cell Lymphoma (DLBCL)
ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to develop a prognostic index for elderly patients with newly diagnosed cHL starting from a prospective observational study of consecutive cases registered after the completion of the Comprehensive Geriatric Assessment (CGA) Prospective data collection study of a consecutive series of newly diagnosed elderly cHL patients undergoing CGA before any therapy with the use of ADL, IADL and CIRS-G. Patients who will be considered not eligible to receive treatment or to be given only palliative therapy after CGA assessment are eligible for the study. Patients will be screened and restaged according to clinical practice instrumental and laboratory assessments timing and type of examinations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Classical Hodgkin Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Newly diagnosed elderly cHL patients

Newly diagnosed elderly cHL patients undergoing CGA before any therapy (treatment for clinical practise) with the use of ADL, IADL and CIRS-G. Patients who will be considered not eligible to receive treatment or to be given only palliative therapy after CGA assessment are eligible for the study

Treatment for clinical practise

Intervention Type OTHER

Prospective data collection with the aim to to develop a prognostic index for elderly patients with newly diagnosed cHL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment for clinical practise

Prospective data collection with the aim to to develop a prognostic index for elderly patients with newly diagnosed cHL

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosis of classical Hodgkin Lymphoma
2. Age ≥ 65 year
3. Evaluation of Comprehensive Geriatric Assessment at baseline
4. Signed informed consent
5. Previously untreated patients

Exclusion Criteria

None
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Italiana Linfomi - ETS

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vittorio Ruggero Zilioli, MD

Role: PRINCIPAL_INVESTIGATOR

SC Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano - Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SC Ematologia AO SS. Antonio e Biagio e C. Arrigo

Alessandria, , Italy

Site Status NOT_YET_RECRUITING

Università Politecnica delle Marche - Clinica di Ematologia

Ancona, , Italy

Site Status RECRUITING

Azienda Ospedaliera S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico

Avellino, , Italy

Site Status NOT_YET_RECRUITING

Centro Riferimento Oncologico - S.O.C. Oncologia Medica A

Aviano, , Italy

Site Status RECRUITING

AOU Policlinico Consorziale - U.O. Ematologia con Trapianto

Bari, , Italy

Site Status RECRUITING

Ospedale "Monsignor Raffaele Dimiccoli" - Ematologia

Barletta, , Italy

Site Status NOT_YET_RECRUITING

ASST Spedali Civili di Brescia - Ematologia

Brescia, , Italy

Site Status RECRUITING

Ospedale Businco - Ematologia

Cagliari, , Italy

Site Status NOT_YET_RECRUITING

Università Cattolica del Sacro Cuore - Ematologia

Campobasso, , Italy

Site Status NOT_YET_RECRUITING

Ospedale di Castelfranco Veneto - Ematologia

Castelfranco Veneto, , Italy

Site Status RECRUITING

Azienda Ospedaliera di Cosenza - UOC Ematologia

Cosenza, , Italy

Site Status NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia

Florence, , Italy

Site Status RECRUITING

UOC Ematologia PO Spaziani

Frosinone, , Italy

Site Status NOT_YET_RECRUITING

Ospedali Riuniti del Canavese - S.C. Medicina trasfusionale ed Ematologia

Ivrea, , Italy

Site Status NOT_YET_RECRUITING

Ospedale Madonna delle Grazie - Ematologia

Matera, , Italy

Site Status NOT_YET_RECRUITING

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia

Meldola, , Italy

Site Status NOT_YET_RECRUITING

ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia

Milan, , Italy

Site Status RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia

Milan, , Italy

Site Status RECRUITING

Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia

Milan, , Italy

Site Status NOT_YET_RECRUITING

Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda - Ematologia

Milan, , Italy

Site Status RECRUITING

AOU Università degli Studi della Campania Luigi Vanvitelli - Oncologia Medica ed Ematologia

Napoli, , Italy

Site Status RECRUITING

AOU Maggiore della Carità di Novara - SCDU Ematologia

Novara, , Italy

Site Status RECRUITING

AOU di Padova - Ematologia

Padua, , Italy

Site Status NOT_YET_RECRUITING

I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1

Padua, , Italy

Site Status RECRUITING

AOU Policlinico Giaccone - Ematologia

Palermo, , Italy

Site Status RECRUITING

AOU di Parma - UO Ematologia e CTMO

Parma, , Italy

Site Status NOT_YET_RECRUITING

IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia

Pavia, , Italy

Site Status RECRUITING

Ospedale S. Maria della Misericordia - Ematologia

Perugia, , Italy

Site Status RECRUITING

Ospedale Guglielmo da Saliceto - U.O. Ematologia

Piacenza, , Italy

Site Status RECRUITING

Ospedale delle Croci - Ematologia

Ravenna, , Italy

Site Status RECRUITING

Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia

Reggio Emilia, , Italy

Site Status RECRUITING

Ospedale degli Infermi di Rimini - U.O. di Ematologia

Rimini, , Italy

Site Status RECRUITING

AO Sant'Andrea - Ematologia

Roma, , Italy

Site Status NOT_YET_RECRUITING

Ospedale S. Camillo - Ematologia

Roma, , Italy

Site Status RECRUITING

Università Cattolica S. Cuore - Ematologia

Roma, , Italy

Site Status NOT_YET_RECRUITING

Istituto Clinico Humanitas - U.O. Ematologia

Rozzano, , Italy

Site Status RECRUITING

Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico

Sassuolo, , Italy

Site Status RECRUITING

AOU Senese - U.O.C. Ematologia

Siena, , Italy

Site Status RECRUITING

Azienda Ospedaliera della Valtellina e della Valchiavenna P.O. Sondrio - Medicina Interna - Centro Malattie del Sangue P.O. Sondrio

Sondrio, , Italy

Site Status RECRUITING

A.O. S. Maria di Terni - S.C. Oncoematologia

Terni, , Italy

Site Status RECRUITING

A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria

Torino, , Italy

Site Status RECRUITING

A.O.U. Citta della Salute e della Scienza di Torino - S.C. Ematologia

Torino, , Italy

Site Status RECRUITING

Ospedale Ca Foncello - S.C di Ematologia

Treviso, , Italy

Site Status RECRUITING

A.O. C. Panico - U.O.C Ematologia e Trapianto

Tricase, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vittorio Ruggero Zilioli, MD

Role: CONTACT

[email protected]
+39 02 64442668

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Manuela Zanni, MD

Role: primary

[email protected]

Guido Gini, MD

Role: primary

[email protected]

Giuseppe Rodolfo Nunziata, MD

Role: primary

[email protected]

Michele Spina, MD

Role: primary

[email protected]

Giorgina Specchia, Prof

Role: primary

[email protected]

Giuseppe Tarantini, MD

Role: primary

[email protected]

Alessandra Tucci, MD

Role: primary

[email protected]

Stefania Massidda, MD

Role: primary

[email protected]

Sergio Storti, MD

Role: primary

[email protected]

Roberto Sartori, MD

Role: primary

[email protected]

Massimo Gentile, MD

Role: primary

[email protected]

Luigi Rigacci, MD

Role: primary

[email protected]

Alessandro Andriani, MD

Role: primary

[email protected]

Roberto Freilone, MD

Role: primary

[email protected]

Alberto Fragasso, MD

Role: primary

[email protected]

Gerardo Musuraca, MD

Role: primary

[email protected]

Vittorio Ruggero Zilioli, MD

Role: primary

[email protected]

Chiara Rusconi, MD

Role: primary

[email protected]

Andrés Ferreri, MD

Role: primary

[email protected]

Francesca Gaia Rossi, MD

Role: primary

[email protected]

Antonello Sica, MD

Role: primary

[email protected]

Luca Nassi, MD

Role: primary

[email protected]

Livio Trentin, MD

Role: primary

[email protected]

Dario Marino, MD

Role: primary

[email protected]

Salvatrice Mancuso, MD

Role: primary

[email protected]

Francesca Re, MD

Role: primary

[email protected]

Manuel Gotti, MD

Role: primary

[email protected]

Leonardo Flenghi, MD

Role: primary

[email protected]

Annalisa Arcari, MD

Role: primary

[email protected]

Monica Tani, MD

Role: primary

[email protected]

Francesco Merli, MD

Role: primary

[email protected]

Anna Lia Molinari, MD

Role: primary

[email protected]

Maria Christina Cox, MD

Role: primary

[email protected]

Roberta Battistini, MD

Role: primary

[email protected]

Stefan Hohaus, Prof

Role: primary

[email protected]

Francesca Ricci, MD

Role: primary

[email protected]

Sara Bigliardi, MD

Role: primary

[email protected]

Alberto Fabbri, MD

Role: primary

[email protected]

Andrea Maria Soccodato, MD

Role: primary

[email protected]

Anna Marina Liberati, Prof

Role: primary

[email protected]

Federica Cavallo, MD

Role: primary

[email protected]

Barbara Botto, MD

Role: primary

[email protected]

Elisabetta Scarpa, MD

Role: primary

[email protected]

Vincenzo Pavone, MD

Role: primary

[email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FIL_ELDHL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 RECRUITING NA
Gonadal Toxicity in Women With Hodgkin Lymphoma
NCT01008735 UNKNOWN
Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
NCT02247869 COMPLETED PHASE2
Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents
NCT06814860 COMPLETED
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205 RECRUITING
Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
NCT06733987 RECRUITING
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
NCT04298619 COMPLETED
Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic
NCT01833884 COMPLETED NA
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
NCT04113226 UNKNOWN PHASE2
Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas
NCT03161054 COMPLETED PHASE2
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
NCT01478269 COMPLETED
Study on Plasmablastic Lymphoma Patients
NCT06781359 RECRUITING
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma
NCT02555267 COMPLETED
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
NCT00902434 COMPLETED
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma
NCT02495454 TERMINATED PHASE2
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
NCT01142674 COMPLETED
Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients
NCT05663983 UNKNOWN
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 COMPLETED PHASE2
Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma
NCT04183569 UNKNOWN
A Phase II Study of the FIL on Elderly Frail Patients With DLBCL
NCT02955823 COMPLETED PHASE2
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 COMPLETED
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
NCT05977673 RECRUITING PHASE2
Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.
NCT00355199 COMPLETED PHASE3
Indolent Non Follicular Lymphomas Prognostic Project
NCT02904577 COMPLETED
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223 COMPLETED